These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7731241)

  • 1. Keystone symposium. Discovery of therapeutic agents. Lake Tahoe, California, March 9-15, 1995. Abstracts.
    J Cell Biochem Suppl; 1995; 19B():347-56. PubMed ID: 7731241
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects and progress in drug design based on peptides and proteins. Keystone symposium. Lake Tahoe, California, March 6-12, 1993. Abstracts.
    J Cell Biochem Suppl; 1993; 17C():201-37. PubMed ID: 8095082
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Biology of Aging. Keystone Symposium. Lake Tahoe, California, March 19-25, 1993. Abstracts.
    J Cell Biochem Suppl; 1993; 17D():139-68. PubMed ID: 8098382
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast and Prostate Cancer II. Keystone Symposium. Lake Tahoe, California, March 14-20, 1994. Abstracts.
    J Cell Biochem Suppl; 1994; 18D():219-54. PubMed ID: 7911540
    [No Abstract]   [Full Text] [Related]  

  • 5. Keystone symposium. Processing enzymes: biochemistry, genetics and clinical relevance. Lake Tahoe, California, March 2-8, 1995. Abstracts.
    J Cell Biochem Suppl; 1995; 19B():229-56. PubMed ID: 7731237
    [No Abstract]   [Full Text] [Related]  

  • 6. Environmental Biotechnology. Keystone symposium. Lake Tahoe, California, March 16-22, 1995. Abstracts.
    J Cell Biochem Suppl; 1995; 21A():37-53. PubMed ID: 7596144
    [No Abstract]   [Full Text] [Related]  

  • 7. Environmental bioremediation and biodegradation. Keystone symposium. Lake Tahoe, California. March 6-12, 1993. Abstracts.
    J Cell Biochem Suppl; 1993; 17C():181-200. PubMed ID: 8095081
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody Engineering: Research and Application of Genes Encoding Immunoglobulins. Keystone Symposium. Lake Tahoe, California, March 7-13, 1994. Abstracts.
    J Cell Biochem Suppl; 1994; 18D():179-217. PubMed ID: 7911538
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular Biology of Human Pathogenic Viruses. Keystone Symposium. Lake Tahoe, California, March 13-18, 1993. Abstracts.
    J Cell Biochem Suppl; 1993; 17D():1-29. PubMed ID: 8098381
    [No Abstract]   [Full Text] [Related]  

  • 10. Keystone symposium. Drug delivery: barriers to drug transport and the design of novel therapeutic agents. Hilton Head Island, South Carolina, January 7-13, 1995. Abstracts.
    J Cell Biochem Suppl; 1995; 19A():163-79. PubMed ID: 7731225
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery and Development of Therapeutic Compounds. Keystone Symposium. Snowmass, Colorado, March 20-26, 1993. Abstracts.
    J Cell Biochem Suppl; 1993; 17D():169-81. PubMed ID: 8098383
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology.
    Ariëns EJ; Wuis EW; Veringa EJ
    Biochem Pharmacol; 1988 Jan; 37(1):9-18. PubMed ID: 3276322
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear receptor superfamily reunion. Keystone Symposium Nuclear Receptor Superfamily, Lake Tahoe, California, USA. 17-23 March 1996.
    Parker MG
    Trends Genet; 1996 Jul; 12(7):277-8. PubMed ID: 8763501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Supramolecular Pharmaceutical Sciences: A Novel Concept Combining Pharmaceutical Sciences and Supramolecular Chemistry].
    Iohara D; Higashi T
    Yakugaku Zasshi; 2019; 139(2):141-142. PubMed ID: 30713222
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathologist and toxicologist in pharmaceutical product discovery.
    Alden CL; Sagartz JE; Smith PF; Wilson AG; Bunch RT; Morris DL
    Toxicol Pathol; 1999; 27(1):104-6. PubMed ID: 10367682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing drug discovery and development. Proceedings of the Lake Tahoe Molecular Diversity Symposia. January 29-February 2, 2001. Lake Tahoe, USA.
    J Cell Biochem Suppl; 2001; Suppl 37():v-vi, 1-137. PubMed ID: 11977199
    [No Abstract]   [Full Text] [Related]  

  • 17. Abstracts of the Dutch Society for Clinical Pharmacology and Biopharmacy. 8 October 2001.
    Br J Clin Pharmacol; 2002 May; 53(5):543P-559P. PubMed ID: 12430172
    [No Abstract]   [Full Text] [Related]  

  • 18. Conference report--protein kinase inhibitors in cancer treatment: mixing and matching? Highlights of the keystone symposium on protein kinases and cancer; February 24-29, 2004; Lake Tahoe, California.
    Novak K
    MedGenMed; 2004 Apr; 6(2):25. PubMed ID: 15266251
    [No Abstract]   [Full Text] [Related]  

  • 19. Symposium on Enzyme Inhibition and Drug Discovery. Antwerp, Belgium, 6 November 1992. Abstracts.
    Pharm Weekbl Sci; 1992 Dec; 14(6 Suppl I):I1-13. PubMed ID: 1361227
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans.
    Lesko LJ; Rowland M; Peck CC; Blaschke TF; Breimer D; de Jong HJ; Grahnen A; Kuhlmann JJ; Stewart B
    Eur J Pharm Sci; 2000; 10(4):iv-xiv. PubMed ID: 11023342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.